Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CRISPR THERAPEUTICS AG
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 157,396 shares of CRSP (CRISPR THERAPEUTICS AG), worth $7.5M as of 2026-Q1. The position was increased (+5.7% shares). CRSP represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$7.5M
Current Shares
157,396
Total Value Change
-$30M
Total Shares Change
-536,562
Other major holders of CRSP: CAPITAL FUND MANAGEMENT S.A., BNP PARIBAS FINANCIAL MARKETS
Increased |
| 157,396 |
+5.7% |
| $7.5M |
| 0.0% |
| $58.06 |
29 |
| 2025-Q4 | New | 148,901 | - | $7.8M | 0.0% | $53.19 | 38 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $63.77 | 0 |
| 2025-Q2 | Decreased | 964,690 | -50.6% | $46.9M | 0.0% | $47.49 | 0 |
| 2025-Q1 | Increased | 2M | +182.9% | $66.5M | 0.0% | $36.99 | 48 |
| 2024-Q4 | Increased | 690,191 | +2.0% | $27.2M | 0.0% | $38.65 | 29 |
| 2024-Q3 | Decreased | 676,326 | -2.5% | $31.8M | 0.0% | $47.32 | 0 |
| 2024-Q2 | Increased | 693,958 | +528.2% | $37.5M | 0.0% | $54.01 | 47 |